Zinger Key Points
- Jim Cramer says First Solar is a "very inexpensive" stock.
- "I would start a position right now," Cramer on Waste Management.
- Get Wall Street's Hottest Chart Every Morning
On CNBC's “Mad Money Lightning Round,” Jim Cramer said First Solar, Inc. FSLR is a “very inexpensive” stock.
First Solar, meanwhile, will report financial results for the fourth quarter and full year ended Dec. 31, 2024, after the closing bell on Tuesday, Feb. 25, 2025.
Shares His Views On These Health Care Stocks
When asked about Viking Therapeutics, Inc. VKTX, Cramer said he prefers Eli Lilly and Company LLY.
In the recent news, Viking Therapeutics, on Jan. 8, announced the initiation of Phase 2 VENTURE-oral dosing trial of VK2735 tablet formulation in patients with obesity.
“This group is just not strong enough, that includes this one. Let's give it a pause for a second,” Cramer said when asked about RadNet, Inc. RDNT. “It was a great stock for a long time, I need to see a real bottom.”
Barclays analyst Andrew Mok, on Jan. 22, maintained RadNet with an Overweight rating and lowered the price target from $85 to $74, while Truist Securities analyst David Macdonald reiterated the stock with a Buy and slashed the price target from $94 to $88.
Likes This Industrial Stock Very Much
The “Mad Money” host said he likes Waste Management, Inc. WM very much, adding that it's an “absolutely terrific” stock. He added, “I would start a position right now.”
Supporting his view, Scotiabank analyst Konark Gupta, on Monday, upgraded Waste Management from Sector Perform to Sector Outperform and raised the price target from $225 to $250.
Price Action:
- Viking Therapeutics shares gained 2.6% to settle at $34.32 on Tuesday.
- First Solar shares fell 2.5% to close at $160.24 during the session.
- RadNet shares gained 4.2% to settle at $65.94 on Tuesday.
- Waste Management shares rose 0.01% to settle at $213.65 on Tuesday.
Read Next:
Image: Shutterstock
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.